Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
Prepping & Survival

Russia’s Cancer “Vaccine” Will Rollout This Fall

Ignoring the obvious question of how anyone could create a “vaccine” for a metabolic disease, Russia has said it’s done it and it’ll be available this fall. The new cancer vaccine is a personalized treatment designed to target malignant tumors using the patient’s own genetic information.

If cancer is truly a metabolic disease, as science is discovering, then how can a “vaccine” prevent it? A vaccine is defined as a biological preparation that improves immunity to a particular disease by stimulating the body’s immune system to recognize and destroy specific pathogens or their components.

Developed with the help of artificial intelligence, the messenger RNA (mRNA) technology allows the vaccine to be tailored to each individual’s specific cancer profile, offering a potentially more effective and targeted therapy.

“All documentation was submitted to the Ministry of Health some time ago, and we hope that the Herzen Institute, the Blokhin Center, and our institute will soon receive approval to begin production of the first vaccine types personalized against melanoma,” Gintsburg said during a roundtable event.

According to Alexander Gintsburg, head of the Gamaleya Research Institute of Epidemiology and Microbiology, as cited by TASS, Russian cancer patients will begin receiving the vaccine this fall.

Some studies have shown that all vaccines, including those made to stop cancer, may actually accelerate the development of the disease. It may be better to focus on the root cause of cancer and preventative treatments, rather than rely on a pharmaceutical intervention to cure something that we haven’t had a cure for yet.

All mRNA Injections, Including Cancer Vaccines, May Accelerate the Development of Cancer

Earlier this month, Veronika Skvortsova, head of the Federal Medical-Biological Agency, stated that the new cancer vaccine demonstrated high effectiveness during preclinical testing and is ready for clinical application, according to a report by RT. 

The last big announcement of an mRNA vaccine was the one created to combat COVID-19 under the United States’ Operation Warp Speed. The results of that vaccination campaign have been nothing short of disastrous.

Read the full article here

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button